Merck & Co. Statistics

Total Valuation

Merck & Co. has a market cap or net worth of EUR 238.11 billion. The enterprise value is 260.76 billion.

Market Cap	238.11B
Enterprise Value	260.76B

Important Dates

The next estimated earnings date is Tuesday, February 4, 2025.

Earnings Date	Feb 4, 2025
Ex-Dividend Date	Dec 16, 2024

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	-0.25%
Shares Change (QoQ)	-0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	2.53B

Valuation Ratios

The trailing PE ratio is 21.86.

PE Ratio	21.86
Forward PE	n/a
PS Ratio	n/a
PB Ratio	n/a
P/TBV Ratio	45.83
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 11.67, with an EV/FCF ratio of 19.60.

EV / Earnings	23.94
EV / Sales	4.30
EV / EBITDA	11.67
EV / EBIT	14.38
EV / FCF	19.60

Financial Position

The company has a current ratio of 1.36, with a Debt / Equity ratio of 0.86.

Current Ratio	1.36
Quick Ratio	0.92
Debt / Equity	0.86
Debt / EBITDA	1.64
Debt / FCF	2.57
Interest Coverage	15.08

Financial Efficiency

Return on equity (ROE) is 28.33% and return on invested capital (ROIC) is 14.87%.

Return on Equity (ROE)	28.33%
Return on Assets (ROA)	10.53%
Return on Capital (ROIC)	14.87%
Revenue Per Employee	797,772
Profits Per Employee	153,407
Employee Count	72,000
Asset Turnover	0.56
Inventory Turnover	2.39

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -2.06% in the last 52 weeks. The beta is 0.40, so Merck & Co.'s price volatility has been lower than the market average.

Beta (5Y)	0.40
52-Week Price Change	-2.06%
50-Day Moving Average	96.18
200-Day Moving Average	108.89
Relative Strength Index (RSI)	44.57
Average Volume (20 Days)	1,461

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.89

Income Statement

In the last 12 months, Merck & Co. had revenue of EUR 56.64 billion and earned 10.89 billion in profits. Earnings per share was 4.29.

Revenue	56.64B
Gross Profit	43.38B
Operating Income	16.94B
Pretax Income	12.30B
Net Income	10.89B
EBITDA	20.56B
EBIT	16.94B
Earnings Per Share (EPS)	4.29

Full Income Statement

Balance Sheet

The company has 13.08 billion in cash and 34.19 billion in debt, giving a net cash position of -21.10 billion.

Cash & Cash Equivalents	13.08B
Total Debt	34.19B
Net Cash	-21.10B
Net Cash Per Share	n/a
Equity (Book Value)	39.95B
Book Value Per Share	15.76
Working Capital	9.66B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 16.38 billion and capital expenditures -3.07 billion, giving a free cash flow of 13.31 billion.

Operating Cash Flow	16.38B
Capital Expenditures	-3.07B
Free Cash Flow	13.31B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 76.59%, with operating and profit margins of 29.91% and 19.23%.

Gross Margin	76.59%
Operating Margin	29.91%
Pretax Margin	21.72%
Profit Margin	19.23%
EBITDA Margin	36.29%
EBIT Margin	29.91%
FCF Margin	23.49%

Dividends & Yields

This stock pays an annual dividend of 2.89, which amounts to a dividend yield of 3.04%.

Dividend Per Share	2.89
Dividend Yield	3.04%
Dividend Growth (YoY)	5.09%
Years of Dividend Growth	6
Payout Ratio	63.72%
Buyback Yield	0.25%
Shareholder Yield	3.29%
Earnings Yield	n/a
FCF Yield	n/a

Dividend Details

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Merck & Co. has an Altman Z-Score of 4.38.

Altman Z-Score	4.38
Piotroski F-Score	n/a